JNK has a tumorigenic effect in PCa, and the JNK inhibitor SP600125 significantly inhibited the proliferation of human osteolytic PC3 cells [17] and canine osteoblastic/osteolytic Ace-1 cells [18]. Here, MAPK8 is linked to posterior cortical atrophy.